相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of pemafibrate on primary biliary cholangitis with dyslipidemia
Mayumi Yamaguchi et al.
HEPATOLOGY RESEARCH (2022)
The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis
Kazuhito Kawata et al.
HEPATOLOGY RESEARCH (2021)
Changes in disease characteristics of primary biliary cholangitis: An observational retrospective study from 1982 to 2016
Masaaki Takamura et al.
HEPATOLOGY RESEARCH (2021)
The association of histological progression with biochemical response to ursodeoxycholic acid in primary biliary cholangitis
Tadashi Namisaki et al.
HEPATOLOGY RESEARCH (2021)
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis
Lars Bossen et al.
LIVER INTERNATIONAL (2020)
Serum Gas6 and Axl as non-invasive biomarkers of advanced histological stage in primary biliary cholangitis
Manabu Hayashi et al.
HEPATOLOGY RESEARCH (2020)
Association of intestinal and systemic inflammatory biomarkers with immune reconstitution in HIV plus patients on ART
Mariana del Rocio Ruiz-Briseno et al.
JOURNAL OF INFLAMMATION-LONDON (2020)
Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients
Kosuke Kaji et al.
ANTIBIOTICS-BASEL (2020)
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2019)
Identification of clinical risk factors for histological progression of primary biliary cholangitis
Yukihisa Fujinaga et al.
HEPATOLOGY RESEARCH (2019)
Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis
Satoru Joshita et al.
HEPATOLOGY RESEARCH (2019)
The macrophage-related biomarkers sCD163 and sCD206 are released by different shedding mechanisms
Marlene Christina Nielsen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Changes in serum levels of leucine-rich α2-glycoprotein predict prognosis in primary biliary cholangitis
Manabu Hayashi et al.
HEPATOLOGY RESEARCH (2019)
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
Katherine J. P. Schwenger et al.
JHEP REPORTS (2019)
Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation
F. Rainer et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects
Erman Esnafoglu et al.
JOURNAL OF PEDIATRICS (2017)
The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients
Thomas Damgaard Sandahl et al.
PLOS ONE (2017)
Recent advances in the management of pruritus in chronic liver diseases
Kazuto Tajiri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis
Marco Carbone et al.
HEPATOLOGY (2016)
Changing Nomenclature for PBC from Primary Biliary Cirrhosis to Primary Biliary Cholangitis
Atsushi Tanaka et al.
JOURNAL OF GASTROENTEROLOGY (2016)
A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness
Sidsel Rodgaard-Hansen et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2014)
Soluble CD163, a Macrophage Activation Marker, Is Independently Associated With Fibrosis in Patients With Chronic Viral Hepatitis B and C
Konstantin Kazankov et al.
HEPATOLOGY (2014)
Guidelines for the management of primary biliary cirrhosis
Atsumasa Komori et al.
HEPATOLOGY RESEARCH (2014)
Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis
H. Gronbaek et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Macrophages: Central regulators of hepatic fibrogenesis and fibrosis resolution
Prakash Ramachandran et al.
JOURNAL OF HEPATOLOGY (2012)
American Association for the Study of Liver Diseases Endpoints Conference: Design and Endpoints for Clinical Trials in Primary Biliary Cirrhosis
Marina G. Silveira et al.
HEPATOLOGY (2010)
Biliary Apotopes and Anti-Mitochondrial Antibodies Activate Innate Immune Responses in Primary Biliary Cirrhosis
Ana Lleo et al.
HEPATOLOGY (2010)
Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement
Yasuni Nakanuma et al.
PATHOLOGY INTERNATIONAL (2010)
Macrophages: Master Regulators of Inflammation and Fibrosis
Thomas A. Wynn et al.
SEMINARS IN LIVER DISEASE (2010)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Soluble CD163 from activated macrophages predicts mortality in acute liver failure
Holger Jon Moller et al.
JOURNAL OF HEPATOLOGY (2007)
A systematic review of the quality of liver biopsy specimens
E Cholongitas et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort
MI Prince et al.
GUT (2004)
分享论文
